3/24/2023  5:39:18 PM Chg. +1.26 Volume Bid5:40:00 PM Ask5:40:00 PM Market Capitalization Dividend Y. P/E Ratio
97.10EUR +1.31% 2.73 mill.
Turnover: 263.42 mill.
96.00Bid Size: 156 97.11Ask Size: 200 121.62 bill.EUR 3.43% 19.54

Business description

Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi is organized into five global business units: Diabetes and Cardiovascular, General Medicines and Emerging Markets, Sanofi Genzyme, Sanofi Pasteur and Merial. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

Management board & Supervisory board

Paul Hudson
Management board
Jean-Baptiste Chasseloup de Chatillon, Arnaud Robert, Bill Sibold, Brendan O’Callaghan, Dr. John Reed, Julie Van Ongevalle, Natalie Bickford, Olivier Charmeil, Roy Papatheodorou, Thomas Triomphe
Supervisory board
Serge Weinberg, Barbara Lavernos, Carole Piwnica, Ceng-Yann Tran, Christophe Babule, Diane Souza, Fabienne Lecorvaisier, Gilles Schnepp, Lise Kingo, Melanie Lee, Patrick Kron, Paul Hudson, Rachel Duan, Thomas Südhof, Wolfgang Laux

Company data

Name: Sanofi S.A.
Address: 54, Rue La Boétie,F-75008 Paris
Phone: +33-1-53-77-40-00
Fax: +33-1-53-77-43-03
E-mail: -
Internet: www.sanofi-aventis.com
Industry: Healthcare
Sector: Pharmaceutical Industry
Sub sector: Pharmaceuticals
End of financial year: 12/31
Free Float: 88.70%
IPO date: -

Investor relations

Name: George Grofik
IR phone: +33-1-53-77-45-45
IR Fax: -
IR e-mail: investor.relations@sanofi.com

Company calendar

CW 17 | 4/27/2023 Interim Report 1st Quarter/3 Months
CW 21 | 5/25/2023 General Shareholder Meeting
CW 21 | 5/25/2023 Ex-Dividend
CW 21 | 5/26/2023 Record Date
CW 25 | 6/23/2023 Dividend Payment

Main Shareholders